vTv Therapeutics Inc (VTVT) Stock Price

35.59 ▼ -1.66 (-4.46%)
Open: 38.49 Vol: 17.73K Day's range: 35.59 - 39.7114 Jan 16, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
VTVT Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 36.53▼ 36.56▼ 36.71▼ 36.86▼ 36.94▼
MA10 36.74▼ 37.10▼ 37.22▼ 38.80▼ 33.37▲
MA20 37.22▼ 38.33▼ 38.38▼ 38.22▼ 27.57▲
MA50 38.90▼ 38.38▼ 39.59▼ 33.08▲ 21.45▲
MA100 38.26▼ 39.41▼ 38.82▼ 27.02▲ 19.57▲
MA200 39.60▼ 37.55▼ 34.63▲ 22.15▲ 23.50▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.032▼ -0.257▼ -0.240▼ -0.761▼ 0.976▲
RSI 31.093▼ 32.583▼ 36.348▼ 48.240▼ 66.497▲
STOCH 20.849     0.597▼ 1.054▼ 35.165     82.412▲
WILL %R -100.000▼ -100.000▼ -100.000▼ -72.500     -34.752    
CCI -121.893▼ -110.441▼ -93.753     -65.271     79.498    
Latest Filters Detected On VTVT
RSI $VTVT RSI(14) Crossed Below 50 Set Alert
MA $VTVT Price Crossed Below MA(26) Set Alert
▲ GAP $VTVT Open Gap Up %3 Set Alert
▲ GAP $VTVT Open Gap Up %2 Set Alert
vTv Therapeutics Inc News
vTv Therapeutics (VTVT) Upgraded to Buy: Here's What You Should Know
Wednesday, December 24, 2025 09:00 AM
Investors might want to bet on vTv Therapeutics (VTVT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...
vTv Therapeutics and M42’s IROS Announce Submission of Phase 2 Clinical Study Protocol for Cadisegliatin in Type 2 Diabetes to the United Arab Emirates Department of Health
Thursday, December 18, 2025 08:05 AM
HIGH POINT, N.C., Dec. 18, 2025 (GLOBE NEWSWIRE) -- vTv Therapeutics Inc. (Nasdaq: VTVT), a late-stage biopharmaceutical company, today announced a Phase 2 clinical study protocol developed in ...
HC Wainwright & Co. Maintains vTv Therapeutics (VTVT) Buy Recommendation
Friday, December 05, 2025 04:00 PM
Fintel reports that on December 19, 2025, HC Wainwright & Co. maintained coverage of vTv Therapeutics (NasdaqCM:VTVT) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
VTVT historical stock data
date open high low close volume
16/01/26 38.49 39.7114 35.59 35.59 17,726
15/01/26 38.49 40.40 37.25 37.25 15,777
14/01/26 38.49 41.95 38.49 40.01 59,680
13/01/26 33.85 38.725 33.85 37.32 28,165
12/01/26 36.9822 36.9822 32.40 34.12 26,366
09/01/26 41.44 41.44 33.69 35.575 30,200
08/01/26 42.50 42.50 40.81 41.06 15,438
07/01/26 43.042 43.07 39.98 41.99 39,900
06/01/26 43.32 44.00 40.77 42.715 30,500
05/01/26 41.45 43.07 40.42 42.38 25,292
Quote Details
52wk Low:13.46
52wk High:44.00
Vol:17.73K
Avg Vol(3m):261.1K
1Y Chng:+119.83%
1M Chng:+30.03%
Add to Watch List
More Information
Index US Composite
Market Cap. 146.69M